Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

26,715 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26,715 results

Large-scale testing (Phase 3)Ended earlyNCT01387932
What this trial is testing

HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer

Who this might be right for
Hepatocellular Carcinoma
Merit Medical Systems, Inc. 235
Testing effectiveness (Phase 2)Study completedNCT01386632
What this trial is testing

Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Sanford Health 50
Testing effectiveness (Phase 2)UnknownNCT00690963
What this trial is testing

Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory Gating

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AHS Cancer Control Alberta 12
Not applicableActive Not RecruitingNCT05623787
What this trial is testing

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesAppendix Cancer+2 more
Laval University 30
Early research (Phase 1)UnknownNCT04213404
What this trial is testing

Ribociclib and Spartalizumab in R/M HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
National Taiwan University Hospital 13
Early research (Phase 1)Study completedNCT00738452
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Stage I-IIIB Non-Small Cell Lung Cancer After Completion of Radiation Therapy Alone or Combined Radiation Therapy and Chemotherapy

Who this might be right for
Lung Cancer
City of Hope Medical Center 10
Not applicableNot Yet RecruitingNCT06060847
What this trial is testing

Liver Resection and Simultaneous Sleeve Gastrectomy for MS-HCC (LIRESS)

Who this might be right for
Carcinoma, HepatocellularMetabolic Syndrome
Ospedale V. Fazzi 50
Not applicableStudy completedNCT01018147
What this trial is testing

4D Image-guided Adaptive Radiotherapy for Lung Cancer: Patient Image Acquisition

Who this might be right for
Lung Cancer
Virginia Commonwealth University 22
Not applicableLooking for participantsNCT05791149
What this trial is testing

Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity

Who this might be right for
Oral Squamous Cell CarcinomaMaxillo-facial SurgeryBiomarkers+3 more
Centre Hospitalier Universitaire, Amiens 60
Testing effectiveness (Phase 2)WithdrawnNCT02033538
What this trial is testing

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Zhejiang University
Testing effectiveness (Phase 2)UnknownNCT02639858
What this trial is testing

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Samyang Biopharmaceuticals Corporation 31
Testing effectiveness (Phase 2)Ended earlyNCT00087048
What this trial is testing

Topotecan in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 1
Testing effectiveness (Phase 2)UnknownNCT03941626
What this trial is testing

Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies

Who this might be right for
Esophagus CancerHepatomaGlioma+1 more
Shenzhen BinDeBio Ltd. 50
Not applicableLooking for participantsNCT04019678
What this trial is testing

Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.

Who this might be right for
Breast Cancer
Istituto Clinico Humanitas 850
Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04655976
What this trial is testing

Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 758
Early research (Phase 1)UnknownNCT03057340
What this trial is testing

The Treatment of Advanced Lung Cancer With Dribbles Antigen by Targeting Activation of Tcells

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Second Affiliated Hospital, Zhejiang University, School of Medicine 30
Testing effectiveness (Phase 2)Study completedNCT00942734
What this trial is testing

Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head And Neck Cancer
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Looking for participantsNCT06563999
What this trial is testing

Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.

Who this might be right for
Lung Cancer Stage IIIMutation
Sun Yat-sen University 120
Early research (Phase 1)Study completedNCT00697632
What this trial is testing

Safety Study of Oral MGCD265 Administered Without Interruption to Subjects With Advanced Malignancies

Who this might be right for
Advanced Cancer
Mirati Therapeutics Inc. 180
Next Page